Almoosa Health (4018) Stock Overview
Operates as a private healthcare provider in the Kingdom of Saudi Arabia. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
4018 Community Fair Values
Create NarrativeSee what 7 others think this stock is worth. Follow their fair value or set your own to get alerts.
Almoosa Health Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ر.س143.80 |
| 52 Week High | ر.س212.00 |
| 52 Week Low | ر.س128.30 |
| Beta | 0 |
| 1 Month Change | 8.20% |
| 3 Month Change | -10.29% |
| 1 Year Change | -12.95% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -1.51% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4018 | SA Healthcare | SA Market | |
|---|---|---|---|
| 7D | 6.7% | 0.7% | 1.5% |
| 1Y | -13.0% | -13.3% | 4.7% |
Return vs Industry: 4018 matched the SA Healthcare industry which returned -13.4% over the past year.
Return vs Market: 4018 underperformed the SA Market which returned 4.1% over the past year.
Price Volatility
| 4018 volatility | |
|---|---|
| 4018 Average Weekly Movement | 5.4% |
| Healthcare Industry Average Movement | 5.4% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in SA Market | 7.8% |
| 10% least volatile stocks in SA Market | 3.0% |
Stable Share Price: 4018 has not had significant price volatility in the past 3 months compared to the SA market.
Volatility Over Time: 4018's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | n/a | Malek Abdulaziz Al Moosa | almoosahealthgroup.org |
Almoosa Health Company operates as a private healthcare provider in the Kingdom of Saudi Arabia. The company stores medical items; and sells medicines, cosmetics, and disposable medical items. It also operates medical centers, including pelvic floor disorders therapy program, musculoskeletal and pediatric rehabilitation, adaptive sport rehabilitation, respiratory diseases clinic, and urology clinic; and women’s health, surgery, emergency, gastroenterology, nephrology and dialysis, pediatric, aesthetic, primary care, diabetes and endocrinology, dental, eye, orthopedic, fertility, obesity, neuroscience, oncology, ear, nose, and throat centers, as well as group therapies.
Almoosa Health Company Fundamentals Summary
| 4018 fundamental statistics | |
|---|---|
| Market cap | ر.س6.37b |
| Earnings (TTM) | ر.س236.54m |
| Revenue (TTM) | ر.س1.42b |
Is 4018 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4018 income statement (TTM) | |
|---|---|
| Revenue | ر.س1.42b |
| Cost of Revenue | ر.س993.19m |
| Gross Profit | ر.س423.10m |
| Other Expenses | ر.س186.55m |
| Earnings | ر.س236.54m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.34 |
| Gross Margin | 29.87% |
| Net Profit Margin | 16.70% |
| Debt/Equity Ratio | 40.7% |
How did 4018 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/16 01:32 |
| End of Day Share Price | 2026/04/16 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Almoosa Health Company is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jassim Al-Jubran | Aljazira Capital Company |
| Ibrahim Elaiwat | Aljazira Capital Company |
| Ahmed Moataz | EFG-Hermes Research |